Status: current, Defined. Date: 29-Feb 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1535311000168111 | ascorbic acid + copper + d-alpha-tocopheryl acid succinate + lutein + zeaxanthin + zinc (medicinal product) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1535321000168116 | ascorbic acid + d-alpha-tocopheryl acid succinate + zinc + copper + lutein + zeaxanthin | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| ascorbic acid + d-alpha-tocopheryl acid succinate + zinc + copper + lutein + zeaxanthin | Is a | lutein + zeaxanthin | true | Inferred relationship | Some | ||
| ascorbic acid + d-alpha-tocopheryl acid succinate + zinc + copper + lutein + zeaxanthin | Is a | ascorbic acid + d-alpha-tocopheryl acid succinate + zinc + copper | true | Inferred relationship | Some | ||
| ascorbic acid + d-alpha-tocopheryl acid succinate + zinc + copper + lutein + zeaxanthin | has intended active ingredient | zinc | true | Inferred relationship | Some | 6 | |
| ascorbic acid + d-alpha-tocopheryl acid succinate + zinc + copper + lutein + zeaxanthin | has intended active ingredient | ascorbic acid | true | Inferred relationship | Some | 1 | |
| ascorbic acid + d-alpha-tocopheryl acid succinate + zinc + copper + lutein + zeaxanthin | has intended active ingredient | copper | true | Inferred relationship | Some | 3 | |
| ascorbic acid + d-alpha-tocopheryl acid succinate + zinc + copper + lutein + zeaxanthin | has intended active ingredient | d-alpha-tocopheryl acid succinate | true | Inferred relationship | Some | 5 | |
| ascorbic acid + d-alpha-tocopheryl acid succinate + zinc + copper + lutein + zeaxanthin | has intended active ingredient | lutein | true | Inferred relationship | Some | 2 | |
| ascorbic acid + d-alpha-tocopheryl acid succinate + zinc + copper + lutein + zeaxanthin | has intended active ingredient | zeaxanthin | true | Inferred relationship | Some | 4 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| ascorbic acid 250 mg + d-alpha-tocopheryl acid succinate 165 mg (200 units) + zinc oxide 49.8 mg (zinc 40 mg) + cupric oxide 1.25 mg (copper 1 mg) + lutein 5 mg + zeaxanthin 1 mg tablet | Is a | True | ascorbic acid + d-alpha-tocopheryl acid succinate + zinc + copper + lutein + zeaxanthin | Inferred relationship | Some |
Reference Sets
Medicinal product reference set
FHIR